NMPA Approval

Iopromide Injection

Approval Number

国药准字HJ20171333

Registration Date

July 18, 2022

Previous Approval Numbers

H20171333

Drug Information

Generic Name

碘普罗胺注射液

Trade Name

优维显

Dosage Form

注射剂

Strength

100ml:76.89g

Drug Type

化学药品

Registration Date

July 18, 2022

Expiry Date

July 17, 2027

Company Address

51368 Leverkusen, Germany

Company NameBAYER AG

Company Address

Müllerstrasse 178, 13353 Berlin, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

碘普罗胺注射液 - NMPA 批准文号 | MedPath